Amanote Research
Register
Sign In
Sub-Macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
Case Medical Research
doi 10.31525/ct1-nct03975088
Full Text
Open PDF
Abstract
Available in
full text
Date
June 5, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Surgical Cystotomy for Refractory Diabetic Cystoid Macular Edema
Clinical Ophthalmology
Ophthalmology
Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
New Strategies for Treatment of Diabetic Macular Edema
Journal of Ophthalmology
Ophthalmology
Efficacy of Sub-Tenon’s Capsule Injection of Triamcinolone Acetonide for Refractory Diabetic Macular Edema After Vitrectomy
Journal of Medical Investigation
Biochemistry
Medicine
Genetics
Molecular Biology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Macular Edema Surgical Treatment
The Macular Function and Structure in Patients With Diabetic Macular Edema Before and After Ranibizumab Treatment
Documenta Ophthalmologica
Ophthalmology
Sensory Systems
Physiology
Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema
Clinical Ophthalmology
Ophthalmology